Clinical trial
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
NCT00071448 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00071448 |
|---|---|
| Title | Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population |
| Official title | Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | insulin human, insulin lispro, insulin aspart |
| Enrollment | 378 |
| Start date | Jun 1, 2002 |
| Primary completion | Jun 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Oct 24, 2003 |
| Last update posted | Dec 22, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: